Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wirth

Showing results (621-630 of 675) with videos related to

Pageof 68
Sort By:
Thyroid : Official Journal of the American Thyroid Association|October 26, 2019
A Novel <i>ALK</i> Fusion in Pediatric Medullary Thyroid CarcinomaKirsty Hillier, Amy Hughes, Robert C Shamberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2022
Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)Alan L Ho, Marek Dedecjus, Lori J Wirth, et al.
Cancer|September 21, 2016
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neckAntonio Jimeno, Marshall R Posner, Lori J Wirth, et al.
NPJ Precision Oncology|August 22, 2025
Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancerDaniel A Ruiz-Torres, Ross D Merkin, Michael E Bryan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 5, 2022
Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor TherapyOr Kalchiem-Dekel, Christina J Falcon, Christine M Bestvina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2021
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid CancerLori J Wirth, Marcia S Brose, Eric J Sherman, et al.
World Journal of Urology|October 13, 2016
Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tractG J Wirth, A Haitel, M Moschini, et al.
Journal of Stroke|February 7, 2018
Incidental Statin Use and the Risk of Stroke or Transient Ischemic Attack after Radiotherapy for Head and Neck CancerDaniel Addison, Patrick R Lawler, Hamed Emami, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 9, 2020
Testing a theoretical model of imminent fracture risk in elderly women: an observational cohort analysis of the Canadian Multicentre Osteoporosis StudyA Papaioannou, J D Adachi, C Berger, et al.
Thyroid : Official Journal of the American Thyroid Association|July 14, 2024
<i>FGFR</i> Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid MalignancyMark F Sabbagh, Tyler Janovitz, Dora Dias-Santagata, et al.
Pageof 68

Showing results (621-630 of 675) with videos related to

Sort By:
Pageof 68
Thyroid : Official Journal of the American Thyroid Association|October 26, 2019
A Novel <i>ALK</i> Fusion in Pediatric Medullary Thyroid CarcinomaKirsty Hillier, Amy Hughes, Robert C Shamberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2022
Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)Alan L Ho, Marek Dedecjus, Lori J Wirth, et al.
Cancer|September 21, 2016
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neckAntonio Jimeno, Marshall R Posner, Lori J Wirth, et al.
NPJ Precision Oncology|August 22, 2025
Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancerDaniel A Ruiz-Torres, Ross D Merkin, Michael E Bryan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 5, 2022
Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor TherapyOr Kalchiem-Dekel, Christina J Falcon, Christine M Bestvina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2021
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid CancerLori J Wirth, Marcia S Brose, Eric J Sherman, et al.
World Journal of Urology|October 13, 2016
Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tractG J Wirth, A Haitel, M Moschini, et al.
Journal of Stroke|February 7, 2018
Incidental Statin Use and the Risk of Stroke or Transient Ischemic Attack after Radiotherapy for Head and Neck CancerDaniel Addison, Patrick R Lawler, Hamed Emami, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 9, 2020
Testing a theoretical model of imminent fracture risk in elderly women: an observational cohort analysis of the Canadian Multicentre Osteoporosis StudyA Papaioannou, J D Adachi, C Berger, et al.
Thyroid : Official Journal of the American Thyroid Association|July 14, 2024
<i>FGFR</i> Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid MalignancyMark F Sabbagh, Tyler Janovitz, Dora Dias-Santagata, et al.
Pageof 68